Transseptal Solutions, in collaboration with clinicians, researchers, and scientists worldwide, is developing a steerable sheath using a novel approach of transseptal puncture and left atrium navigation, all in one system.
Transseptal Solutions seeks to improve left-atrium-access procedures and generate an approach for the expanding indications of left-heart treatments.
The company's CE-marked and FDA-approved TSP Crosser is an integrated transseptal system that includes a method to engage the fossa ovalis precisely and efficiently using an extendable radiopaque loop wire and a steerable sheath. The system can precisely navigate a flexible needle for accurate and optimal left-atrium access.
After the puncture, the steerable sheath serves as a guiding catheter for left-side procedures, including transcatheter mitral repair/replacement, PVL closure, atrial fibrillation ablation, and left-atrial appendage occlusion.
